Introduction
Proteus syndrome is a rare congenital neurocutaneous syndrome that was first described in 1979. 1 The etiology of Proteus syndrome, initially unknown, 2-5 started to be described in 2000, with studies reporting mutations in the tumor suppressor gene PTEN. [6] [7] [8] Clinical manifestations are highly variable, but usually affect the brain and other tissues. 8, 9 Main clinical signs are overgrowth of the brain, hemihypertrophy, gigantism of the extremities, skin abnormalities, multiple hamartomatous tumors and mental retardation. 3, 10, 11 Brain radiology findings are also variable, and may include hemimegalencephaly, Seizure (2008) callosal dysgenesis, neuronal migration disorders and calcifications. 12 Finally, epilepsy and epileptic syndromes, often of early onset and hard to control, such as the Ohtahara syndrome, may be associated. 13 Ohtahara syndrome, an early-infantile epileptic encephalopathy, was first described in 1976, 14 and is characterized by frequent epileptic spasms and EEG burst suppression patterns, in which suppression phases usually last longer (up to 10 s) than high voltage spikes (1-3 s) . [15] [16] [17] Clinical signs include flexor, extensor, or flexor-extensor spasms, frequently with clustering, that usually last longer than 10 s and occur during sleeping and waking states. Partial seizures may occur in up to one-third of the cases. 18 The etiology of Ohtahara syndrome is heterogeneous and includes central nervous system (CNS) malformations, such as hemimegalencephaly, [19] [20] [21] porencephaly, Aicardi syndrome, 22 and other conditions. 17, [23] [24] [25] [26] [27] The prognosis is poor due to the intractability of seizures. Mortality is high, particularly among earlyonset cases, and estimated survival is 2 years. 18 This report describes and discusses two cases of infants seen at Hospital de Clínicas de Porto Alegre and reviews the pertinent literature.
Case 1
A female infant born prematurely at 35 weeks' gestational age by cesarean delivery due to acute fetal distress was admitted to the neonatal ICU and required prolonged mechanical ventilation and treatment with antibiotics.
The patient, seen at the emergency department at 4 months of age, had a history of flexor spasms of the four extremities that started in the 2nd month of life at a frequency of 4-5 episodes/day. Prior to being admitted at our department, treatment consisted of monotherapy with phenobarbital (from the second to the 4th month of life).
Examination showed asymmetric syndromic facies, with the left side larger than the right, head circumference above the 98th percentile, flexor hypertonia of the four extremities with hyperreflexia, and persistence of neonatal reflexes. Delays in neurologic and psychomotor development were also identified.
Fundus examination revealed a pale optic papilla and peripheral scars. Skin findings included a flat hemangioma in the occipital region and a nevus depigmentosus in the left mandibular region.
Sleep electroencephalogram (EEG) revealed a high voltage burst suppression pattern with bursts lasting 1-3 s, slow waves and multifocal spikes at burst to burst intervals, and prolonged suppression phases, some of which lasted up to 10 s (Fig. 1) .
Flair magnetic resonance imaging (MRI) revealed left hemimegalencephaly, callosal dysgenesis, pachygyria and polymicrogyria (Fig. 2) .
During follow-up, other anticonvulsant drugs were administered in an attempt to control seizures. At discharge, seizures were partially controlled with valproic acid, primidone, and vigabatrin. Control EEG carried out at 8 months of follow-up showed disorganized and asymmetric background rhythms, amplitude attenuation and no sleep spindles. Frequent and predominantly frontotemporal paroxysms in the left hemisphere and a hypsarrhythmic pattern were also found (Fig. 3) .
Case 2
A 2-month-old female infant born at full term (38 weeks) by cesarean delivery due to acute fetal distress and presenting respiratory dysfunction and sepsis was admitted to the neonatal ICU for 7 days. Initial examination showed facial asymmetry with marked hypertrophy of right side of face, but neurologic examination did not reveal any other abnormal findings.
Cranial tomography showed overgrowth of the right side of brain, gray matter heterotopia in the occipital horn of right lateral ventricle, hypoplasia of the left hemisphere and a hypodense left frontal area.
Onset of seizures in the 2nd month of life was characterized by brief epileptic spasms of upper extremities. Electroencephalogram showed a burst suppression pattern. Bursts lasted 3-5 s and were mixed with prolonged bilateral and mildly asymmetric suppression phases with lower amplitude to the left.
Valproic acid was initiated and the dose was gradually increased, but there was no improvement of seizures. Better control was obtained after the association of vigabatrin.
Discussion
The authors report the cases of two infants with clinical signs and examination findings suggestive of Proteus syndrome, a rare hamartomatous syndrome 380 H. Bastos et al. of complex and variable characteristics associated with hemimegalencephaly. Hemimegalencephaly has already been reported in cases of Proteus syndrome, but there is no consensus about its incidence. After the first description of the syndrome, 1 several authors have reported an increasing variability of findings. In 1991, Goodship et al. 28 described associated congenital anomalies of the CNS in 12 children with Proteus syndrome; of these, eight patients showed evidence of hemimegalencephaly.
In our study, dysmorphic growth, skin abnormalities, CNS malformations and epilepsy were observed. Onset of epilepsy was in the 2nd month of life. Epilepsy progressed severely, and Ohtahara syndrome was diagnosed.
The association of infantile spasms, myoclonias, and partial epilepsy in newborn infants is generally observed in cases with extensive migration disorders diagnosed as Ohtahara syndrome. Guzzeta et al. 30 reported the case of a male newborn with Ohtahara syndrome and right hemimegalencephaly who presented epileptic negative myoclonus on the 1st day of life. Dietrich et al. 29 described three children with hemimegalencephaly among eight patients with early-infantile epileptic encephalopathy with suppression bursts. In spite of these studies reporting the association between Ohtahara syndrome and hemimegalencephaly, there is no consensus on the incidence of such occurrence.
Our review of the literature did not yield any reports of patients with Proteus syndrome associated with both hemimegalencephaly and Ohtahara syndrome. To our knowledge, these are the first reports of the triple association, and therefore it is not possible to describe the incidence of this association or to make comparisons with the literature. In addition, our study might suggest that the occurrence of this triple association is underestimated.
Although prognosis of Proteus syndrome is poor, treatment approaches such as anticonvulsant medication, physiotherapy, and occupational therapy, in addition to family support, may be very helpful. On the other hand, surgical approaches, including esthetic surgeries and hemispherectomy, should be further discussed. Specifically regarding hemispherectomy, which is usually suggested in cases of intractable seizures, we considered this possibility for both of our cases, but could not reach a consensus among the group.
In view of our findings, and since there is no consensus regarding the indication of surgery for hemimegalencephaly, we stress the importance of adopting a multidisciplinary approach to ensure early detection of functional disorders, minimize disabilities, reduce morbidity and mortality. In addition, we hope these findings increase neurologists' attention towards the possibility of diagnosing this triple association.
